Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Bullboard - Investor Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc > It's All Good Beh
View:
Post by DannyDanboy on Jun 04, 2020 4:10pm

It's All Good Beh

I agree with you Beh. At this point I'm done sharing my opinions here and other places with others. Does not matter what Algernon does behind the scenes or how transparent they are with investors people here will always find a way to put a negative spin on it. Algernon releases FDA clearance and now ppl are upset about the hault. LMAO. No pleasing ppl these days I tell you. If you're long you know what a milestone this is. I could care less what we close at today.
Comment by Flyer47 on Jun 04, 2020 5:36pm
Very disappointing to hit milestone after milestone and see the stock more or less flatline over the last few months. I agree maybe 2 or 3 months for report the drug is effective for CC or Covid. Good news or bad before we see much of a change in price.
Comment by BehStreet on Jun 05, 2020 8:21am
Thanks Danny. I don't post on here much anymore for that very reason. The impatience, pessimism, and ignorance is immoderate. Blaming management for the daily tick a stock price isn't worth my reply. We are up over 450% on the year and the company is delivering at lightning speed for a bio-tech. I've done my DD, I can wait months.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Connect with C.AGN


CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Facebook